{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:26:26Z","timestamp":1772331986900,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["28677 (NCITA)"],"award-info":[{"award-number":["28677 (NCITA)"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","award":["NIHR203314"],"award-info":[{"award-number":["NIHR203314"]}],"id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Royal Marsden\/ICR Clinical Research Facility"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Myeloma Response Assessment and Diagnosis System (MY-RADS) guidelines establish a standardised acquisition and analysis pipeline for whole-body MRI (WB-MRI) in patients with myeloma. This is the first study to assess image quality in a multi-centre prospective trial using MY-RADS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The cohort consisted of 121 examinations acquired across ten sites with a range of prior WB-MRI experience, three scanner manufacturers and two field strengths. Image quality was evaluated qualitatively by a radiologist and quantitatively using a semi-automated pipeline to quantify common artefacts and image quality issues. The intra- and inter-rater repeatability of qualitative and quantitative scoring was also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Qualitative radiological scoring found that the image quality was generally good, with 94% of examinations rated as good or excellent and only one examination rated as non-diagnostic. There was a significant correlation between radiological and quantitative scoring for most measures, and intra- and inter-rater repeatability were generally good.<\/jats:p>\n                <jats:p>When the quality of an overall examination was low, this was often due to low quality diffusion-weighted imaging (DWI), where signal to noise ratio (SNR), anterior thoracic signal loss and brain geometric distortion were found as significant predictors of examination quality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is possible to successfully deliver a multi-centre WB-MRI study using the MY-RADS protocol involving scanners with a range of manufacturers, models and field strengths. Quantitative measures of image quality were developed and shown to be significantly correlated with radiological assessment. The SNR of DW images was identified as a significant factor affecting overall examination quality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03188172\">NCT03188172<\/jats:ext-link>, Registered on 15 June 2017.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Critical relevance statement<\/jats:title>\n                <jats:p>Good overall image quality, assessed both qualitatively and quantitatively, can be achieved in a multi-centre whole-body MRI study using the MY-RADS guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key points<\/jats:title>\n                <jats:p>\u2022 A prospective multi-centre WB-MRI study using MY-RADS can be successfully delivered.<\/jats:p>\n                <jats:p>\u2022 Quantitative image quality metrics were developed and correlated with radiological assessment.<\/jats:p>\n                <jats:p>\u2022 SNR in DWI was identified as a significant predictor of quality, allowing for rapid quality adjustment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13244-023-01498-3","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:01:41Z","timestamp":1697403701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-0750","authenticated-orcid":false,"given":"Sam","family":"Keaveney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Dragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Rata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Blackledge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Scurr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Winfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Shur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Candito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchi","family":"Gaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjumara","family":"Nilak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Albrizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Drury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Messiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,15]]},"reference":[{"key":"1498_CR1","first-page":"e210048","volume":"3","author":"C Messiou","year":"2021","unstructured":"Messiou C, Porta N, Sharma B et al (2021) Prospective evaluation of whole-body MRI versus FDG PET\/CT for lesion detection in participants with myeloma. Radiology 3:e210048","journal-title":"Radiology"},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","volume":"20","author":"J Hillengass","year":"2019","unstructured":"Hillengass J, Usmani S, Rajkumar SV et al (2019) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 20:e302\u2013e312","journal-title":"Lancet Oncol"},{"key":"1498_CR3","volume-title":"Myeloma: diagnosis and management","author":"National Institute for Health and Care Excellence (NICE) NG35","year":"2016","unstructured":"National Institute for Health and Care Excellence (NICE) NG35 (2016) Myeloma: diagnosis and management"},{"key":"1498_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S et al (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology 291:5\u201313","journal-title":"Radiology"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.acra.2017.12.008","volume":"25","author":"C Wu","year":"2018","unstructured":"Wu C, Huang J, Xu W-B et al (2018) Discriminating depth of response to therapy in multiple myeloma using whole-body diffusion-weighted MRI with apparent diffusion coefficient: preliminary results from a single-center study. Acad Radiol 25:904\u2013914","journal-title":"Acad Radiol"},{"key":"1498_CR6","doi-asserted-by":"publisher","first-page":"108695","DOI":"10.1016\/j.ejrad.2019.108695","volume":"120","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xiong X, Fu Z et al (2019) Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: a large single-center cohort study. Eur J Radiol 120:108695","journal-title":"Eur J Radiol"},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/bjh.14401","volume":"176","author":"A Latifoltojar","year":"2017","unstructured":"Latifoltojar A, Hall-Craggs M, Rabin N et al (2017) Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response. Br J Haematol 176:222\u2013233","journal-title":"Br J Haematol"},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","volume":"14","author":"JP O'Connor","year":"2017","unstructured":"O\u2019Connor JP, Aboagye EO, Adams JE et al (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 14:169\u2013186","journal-title":"Nat Rev Clin Oncol"},{"key":"1498_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/RLI.0000000000000237","volume":"51","author":"CL Schlett","year":"2016","unstructured":"Schlett CL, Hendel T, Hirsch J et al (2016) Quantitative, organ-specific interscanner and intrascanner variability for 3 T whole-body magnetic resonance imaging in a multicenter, multivendor study. Invest Radiol 51:255\u2013265","journal-title":"Invest Radiol"},{"key":"1498_CR10","doi-asserted-by":"crossref","unstructured":"Michoux NF, Ceranka JW, Vandemeulebroucke J et al (2021) Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study. Eur Radiol 1\u201314","DOI":"10.1007\/s00330-020-07522-0"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jmri.24356","volume":"40","author":"TC Kwee","year":"2014","unstructured":"Kwee TC, Vermoolen MA, Akkerman EA et al (2014) Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study. J Magn Reson Imaging 40:26\u201336","journal-title":"J Magn Reson Imaging"},{"key":"1498_CR12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/jmri.24938","volume":"42","author":"AS Littooij","year":"2015","unstructured":"Littooij AS, Kwee TC, de Keizer B et al (2015) Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: a prospective multicenter study. J Magn Reson Imaging 42:1646\u20131655","journal-title":"J Magn Reson Imaging"},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/RLI.0000000000000838","volume":"57","author":"M Wennmann","year":"2022","unstructured":"Wennmann M, Thierjung H, Bauer F et al (2022) Repeatability and reproducibility of ADC measurements and MRI signal intensity measurements of bone marrow in monoclonal plasma cell disorders: a prospective bi-institutional multiscanner, multiprotocol study. Invest Radiol 57:272\u2013281","journal-title":"Invest Radiol"},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S2213-2600(19)30090-6","volume":"7","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Ball S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. Lancet Respir Med 7:523\u2013532","journal-title":"Lancet Respir Med"},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(19)30056-1","volume":"4","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Beare S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. Lancet Gastroenterol Hepatol 4:529\u2013537","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"e046225","DOI":"10.1136\/bmjopen-2020-046225","volume":"11","author":"S Brown","year":"2021","unstructured":"Brown S, Sherratt D, Hinsley S et al (2021) MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia. BMJ Open 11:e046225","journal-title":"BMJ Open"},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"R Kyle","year":"2009","unstructured":"Kyle R, Rajkumar SV (2009) Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 23:3\u20139","journal-title":"Leukemia"},{"key":"1498_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/leu.2017.179","volume":"32","author":"V Shah","year":"2018","unstructured":"Shah V, Sherborne AL, Walker BA et al (2018) Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Leukemia 32:102\u2013110","journal-title":"Leukemia"},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-022-01253-0","volume":"13","author":"M Rata","year":"2022","unstructured":"Rata M, Blackledge M, Scurr E et al (2022) Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM\/MUKnine multi-centre clinical trial for patients with myeloma. Insights Imaging 13:1\u201316","journal-title":"Insights Imaging"},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2214\/AJR.11.7866","volume":"199","author":"D-M Koh","year":"2012","unstructured":"Koh D-M, Blackledge M, Padhani AR et al (2012) Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 199:252\u2013262","journal-title":"AJR Am J Roentgenol"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"20170577","DOI":"10.1259\/bjr.20170577","volume":"91","author":"A Barnes","year":"2018","unstructured":"Barnes A, Alonzi R, Blackledge M et al (2018) UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer. Br J Radiol 91:20170577","journal-title":"Br J Radiol"},{"key":"1498_CR22","volume-title":"Quantitative Imaging Biomarkers Alliance (QIBA) Profile: Diffusion-Weighted Magnetic Resonance Imaging (DWI), clinically feasible profile","author":"QIBA Dwi Biomarker Committee","year":"2022","unstructured":"QIBA Dwi Biomarker Committee (2022) Quantitative Imaging Biomarkers Alliance (QIBA) Profile: Diffusion-Weighted Magnetic Resonance Imaging (DWI), clinically feasible profile"},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1890\/0012-9658(1999)080[1150:TMAORR]2.0.CO;2","volume":"80","author":"LV Hedges","year":"1999","unstructured":"Hedges LV, Gurevitch J, Curtis PS (1999) The meta-analysis of response ratios in experimental ecology. Ecology 80:1150\u20131156","journal-title":"Ecology"},{"key":"1498_CR24","doi-asserted-by":"crossref","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 159\u201374","DOI":"10.2307\/2529310"},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163","journal-title":"J Chiropr Med"},{"key":"1498_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mri.2018.07.003","volume":"53","author":"T K\u00fcstner","year":"2018","unstructured":"K\u00fcstner T, Gatidis S, Liebgott A et al (2018) A machine-learning framework for automatic reference-free quality assessment in MRI. Magn Reson Imaging 53:134\u2013147","journal-title":"Magn Reson Imaging"},{"key":"1498_CR27","doi-asserted-by":"publisher","first-page":"14154","DOI":"10.1109\/ACCESS.2023.3243466","volume":"11","author":"S Kastryulin","year":"2023","unstructured":"Kastryulin S, Zakirov J, Pezzotti N, Dylov DV (2023) Image quality assessment for magnetic resonance imaging. IEEE Access 11:14154\u201314168","journal-title":"IEEE Access"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-023-01498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-023-01498-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-023-01498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T21:37:58Z","timestamp":1700343478000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-023-01498-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1186\/s13244-023-01498-3","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,15]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written consent for inclusion into the study. ClinicalTrials.gov identifier: NCT03188172.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}